New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
12:00 EDTMO, CVS, LO, RAI, PMCVS plans to stop selling cigarettes and other tobacco products
CVS Caremark (CVS) earlier today announced its decision to cease selling tobacco at all locations starting October 1. WHAT'S NOTABLE: CVS Caremark said its choice to exit the tobacco category does not affect the company's 2014 segment operating profit guidance, 2014 earnings per share guidance, or the company's five-year financial projections. The company estimates that it will lose approximately $2B in revenues on an annual basis from the tobacco shopper, equating to approximately 17c per share. Given the anticipated timing for implementation of this change, the impact to 2014 earnings per share is expected to be in the range of 6c-9c per share. The company has identified incremental opportunities that are expected to offset the profitability impact, CVS added. WHAT'S NOTABLE: Deutsche Bank believes CVS Caremark's decision to stop selling tobacco products is in-line with its strategy to become more of a healthcare services company. Deutsche thinks the move could improve CVS' competitive positioning and it keeps a Hold rating on the stock. PRICE ACTION: During late morning trading, shares of CVS Caremark were down 1.5% to trade near $65. Like the broader S&P 500, shares of a number of tobacco product makers were generally lower. Philip Morris (PM) fell 0.88% to $76.20, Reynolds American (RAI) fell 0.7% to $47.17, Lorillard (LO) fell 2.5% to $47.64 and Altria Group (MO) fell 1.2% to $34.02.
News For CVS;PM;LO;MO;RAI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
08:59 EDTMO, PMAltria Group backs FY15 adjusted EPS $2.75-$2.80, consensus $2.80
Altria (MO) expects to record a one-time, pre-tax charge against reported earnings in Q1, reflecting the loss on early extinguishment of debt related to the tender offer. The final pre-tax charge will depend upon the pricing and amount of notes purchased in the tender offer. EPS guidance excludes the Charge as well as an approximate 2c per share provision that will be recorded by Philip Morris USA (PM) in Q1.
08:23 EDTRAI, LOLorillard appoints CFO David Taylor as Chief Executive of ITG Brands
Subscribe for More Information
February 25, 2015
09:49 EDTMOPhilip Morris USA reaches agreement to resolve federal Engle progency litigation
Subscribe for More Information
09:39 EDTRAI, LO, MOR.J. Reynolds, other makers reach favorable resolution of Engle progeny cases
Subscribe for More Information
09:31 EDTLOLorillard agrees to resolve federal Engle progency cases
Subscribe for More Information
February 24, 2015
13:23 EDTCVSLeerink healthcare technology analyst holds analyst/industry conference call
Healthcare Tech & Distribution Analyst Larsen discusses th 2016 Pharmacy Benefits Management (PBM) selling season, the impact of the Hep C PBM formulary negotiations on the selling season and specialty drug trend and areas of opportunity for PBMs on an Analyst/Industry conference call to be held on March 5 at 2 pm.
10:12 EDTLOOptions with increasing implied volatility: LO ARIA OWW
09:35 EDTMOActive equity options trading on open
Subscribe for More Information
February 23, 2015
10:45 EDTLOOptions with increasing implied volatility
Subscribe for More Information
February 20, 2015
10:49 EDTLOOptions with increasing implied volatility: LO TLM
Subscribe for More Information
February 19, 2015
14:16 EDTLOLorillard increases dividend 7% to 66c
Lorillard announced that its board approved a 7% increase in the quarterly dividend on its common stock to 66c from 61.5c per share. The dividend is payable on March 10 to stockholders of record as of March 2.
February 18, 2015
13:38 EDTPMPhilip Morris reaffirms FY15 EPS view $4.27-$4.37, consensus $4.32
Subscribe for More Information
09:36 EDTPM, MOAltria Group sees shipping e-vapor products for international market in Q1
Subscribe for More Information
09:21 EDTMOAltria Group sees growing long-term adjusted EPS at avg. annual rate of 7%-9%
Subscribe for More Information
07:45 EDTMOAltria Group reaffirms FY15 adjusted EPS view $2.75-$2.80, consensus $2.80
04:55 EDTMOStocks with implied volatility movement; MO ORCL
Subscribe for More Information
February 17, 2015
10:01 EDTCVSCVS says PCSK9 inhibitors could cost system $150B annually
Subscribe for More Information
07:15 EDTRAI, MOConsumer Analyst Group of New York (CAGNY) to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use